Can “Oral l-Methyl Folate” Substitute “Parenteral Folinic Acid” in the Methotrexate-Containing Chemotherapy Protocols in Low-Resource Countries? A Letter to the Editor-Reference-Cited by-同舟云学术

Can “Oral l-Methyl Folate” Substitute “Parenteral Folinic Acid” in the Methotrexate-Containing Chemotherapy Protocols in Low-Resource Countries? A Letter to the Editor

Published:2024-06-24 Issue:3 Volume:22 Page:
ISSN:2363-8397
Container-title:Indian Journal of Gynecologic Oncology
language:en
Short-container-title:Indian J Gynecol Oncolog

Author:

Hemida Reda^ORCID,Eladawei Ghada

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s40944-024-00798-w.pdf

Reference12 articles.

1. Hemida R, Vos E, El-Deek B, Arafa M, Toson E, Burger CW, van Doorn HC. Second uterine curettage and the number of chemotherapy courses in low-risk postmolar gestational trophoblastic neoplasia. A randomized controlled study. Obstet Gynecol. 2019;133(5):1024–31.

2. Howard SC, McCormick J, Pui CH, Buddington RK, Harvey RD. Preventing and managing toxicities of high-dose methotrexate. Oncologist. 2016;21(12):1471–82.

3. Braga A, Elias KM, Horowitz NS, Berkowitz RS. Treatment of high-risk gestational trophoblastic neoplasia and chemoresistance/relapsed disease. Best Pract Res Clin Obstet Gynaecol. 2021;74:81–96.

4. Hamed KM, Dighriri IM, Baomar AF, Alharthy BT, Alenazi FE, Alali GH, Alenazy RH, Alhumaidi NT, Alhulayfi DH, Alotaibi YB, Alhumaidan SS, Alhaddad ZA, Humadi AA, Alzahrani SA, Alobaid RH. Overview of methotrexate toxicity: a comprehensive literature review. Cureus. 2022;14(9): e29518.

5. Ortiz Z, Shea B, Suarez-Almazor ME, Moher D, Wells GA, Tugwell P. The efficacy of folic acid and folinic acid in reducing methotrexate gastrointestinal toxicity in rheumatoid arthritis: a metaanalysis of randomized controlled trials. J Rheumatol. 1998;25:36–43.